Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
196.88
+10.94 (5.88%)
Oct 28, 2025, 3:36 PM EDT - Market open
PRAX Stock Forecast
Stock Price Forecast
The 13 analysts that cover PRAX stock have a consensus rating of "Strong Buy" and an average price target of $202.85, which forecasts a 3.03% increase in the stock price over the next year. The lowest target is $28 and the highest is $360.
Price Target: $202.85 (+3.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 8 |
| Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 10 | 10 | 10 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Sell Maintains $33 → $73 | Sell | Maintains | $33 → $73 | -62.92% | Oct 20, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $85 → $360 | Strong Buy | Reiterates | $85 → $360 | +82.85% | Oct 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $155 → $350 | Strong Buy | Maintains | $155 → $350 | +77.77% | Oct 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $80 → $330 | Strong Buy | Maintains | $80 → $330 | +67.61% | Oct 17, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $65 → $280 | Strong Buy | Maintains | $65 → $280 | +42.22% | Oct 17, 2025 |
Financial Forecast
Revenue This Year
93.50K
from 8.55M
Decreased by -98.91%
Revenue Next Year
124.66K
from 93.50K
Increased by 33.33%
EPS This Year
-13.73
from -10.21
EPS Next Year
-13.02
from -13.73
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.2M | 1.2M | |||
| Avg | 93,503 | 124,664 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -86.5% | 1,135.2% | |||
| Avg | -98.9% | 33.3% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -13.09 | -5.67 | |||
| Avg | -13.73 | -13.02 | |||
| Low | -14.36 | -18.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.